Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

ADAM33 polymorphisms and susceptibility to allergic rhinitis: a meta-analysis

ADAM33 polymorphisms and susceptibility to allergic rhinitis: a meta-analysis Several polymorphisms in a disintegrin and metalloproteinase 33 (ADAM33) have been implicated in susceptibility to allergic rhinitis (AR), but the results are inconclusive. This meta-analysis was aimed to clarify the impact of ADAM33 polymorphisms on AR risk. Pubmed, EMBASE and Cochrane library were searched until 11 October 2013 for eligible studies on seven ADAM33 polymorphisms: T1, T2, S1, S2, V4, Q−1 and T+1. Data were extracted, and pooled odd ratios (ORs) as well as 95 % confidence intervals (CIs) were calculated. Six studies with 1,135 AR patients and 1,565 controls were included. It was found that ADAM33 T1 (AG+GG vs. AA, OR 1.47, 95 % CI 1.23–1.75, I 2 = 94 %; G vs. A, OR 1.53, 95 % CI 1.32–1.78, I 2 = 94 %), T2 (GA+AA vs. GG, OR 1.26, 95 % CI 1.06–1.51, I 2 = 92 %; G vs. A, OR 1.27, 95 % CI 1.08–1.50, I 2 = 92 %), V4 (CG+GG vs. CC OR 1.35, 95 % CI 1.14–1.59, I 2 = 95 %;G vs. C OR 1.28, 95 % CI 1.13–1.44, I 2 = 96 %) and Q−1 (GA+AA vs. GG OR 1.55, 95 % CI 1.24–1.95, I 2 = 74 %; G vs. C OR 1.46, 95 % CI 1.19–1.79, I 2 = 73 %) polymorphisms were significantly associated with AR susceptibility but not S1, S2 and T+1. In Asians, the same result was found. This meta-analysis indicated that ADAM33 T1, T2, V4 and Q−1 polymorphisms may be the risk factors which conferred to AR susceptibility. The differences in ethnicity did not influence the associations obviously. Gene–gene and gene–environment interactions should be investigated in the future. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Archives of Oto-Rhino-Laryngology Springer Journals

ADAM33 polymorphisms and susceptibility to allergic rhinitis: a meta-analysis

Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/adam33-polymorphisms-and-susceptibility-to-allergic-rhinitis-a-meta-RTwhpcDy3M

References (33)

Publisher
Springer Journals
Copyright
Copyright © 2015 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Otorhinolaryngology; Neurosurgery; Head and Neck Surgery
ISSN
0937-4477
eISSN
1434-4726
DOI
10.1007/s00405-014-3130-3
pmid
24908071
Publisher site
See Article on Publisher Site

Abstract

Several polymorphisms in a disintegrin and metalloproteinase 33 (ADAM33) have been implicated in susceptibility to allergic rhinitis (AR), but the results are inconclusive. This meta-analysis was aimed to clarify the impact of ADAM33 polymorphisms on AR risk. Pubmed, EMBASE and Cochrane library were searched until 11 October 2013 for eligible studies on seven ADAM33 polymorphisms: T1, T2, S1, S2, V4, Q−1 and T+1. Data were extracted, and pooled odd ratios (ORs) as well as 95 % confidence intervals (CIs) were calculated. Six studies with 1,135 AR patients and 1,565 controls were included. It was found that ADAM33 T1 (AG+GG vs. AA, OR 1.47, 95 % CI 1.23–1.75, I 2 = 94 %; G vs. A, OR 1.53, 95 % CI 1.32–1.78, I 2 = 94 %), T2 (GA+AA vs. GG, OR 1.26, 95 % CI 1.06–1.51, I 2 = 92 %; G vs. A, OR 1.27, 95 % CI 1.08–1.50, I 2 = 92 %), V4 (CG+GG vs. CC OR 1.35, 95 % CI 1.14–1.59, I 2 = 95 %;G vs. C OR 1.28, 95 % CI 1.13–1.44, I 2 = 96 %) and Q−1 (GA+AA vs. GG OR 1.55, 95 % CI 1.24–1.95, I 2 = 74 %; G vs. C OR 1.46, 95 % CI 1.19–1.79, I 2 = 73 %) polymorphisms were significantly associated with AR susceptibility but not S1, S2 and T+1. In Asians, the same result was found. This meta-analysis indicated that ADAM33 T1, T2, V4 and Q−1 polymorphisms may be the risk factors which conferred to AR susceptibility. The differences in ethnicity did not influence the associations obviously. Gene–gene and gene–environment interactions should be investigated in the future.

Journal

European Archives of Oto-Rhino-Laryngology – Springer Journals

Published: Mar 1, 2015

There are no references for this article.